Cargando…
ABCC3 as a marker for multidrug resistance in non-small cell lung cancer
Multidrug resistance (MDR) contributes to the failure of chemotherapy and high mortality in non-small cell lung cancer (NSCLC). We aim to identify MDR genes that predict tumor response to chemotherapy. 199 NSCLC fresh tissue samples were tested for chemosensitivity by MTT assay. cDNA microarray was...
Autores principales: | Zhao, Yanbin, Lu, Hailing, Yan, An, Yang, Yanmei, Meng, Qingwei, Sun, Lichun, Pang, Hui, Li, Chunhong, Dong, Xiaoqun, Cai, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814586/ https://www.ncbi.nlm.nih.gov/pubmed/24176985 http://dx.doi.org/10.1038/srep03120 |
Ejemplares similares
-
Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition
por: Meng, Qingwei, et al.
Publicado: (2016) -
Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
por: Sun, Yue-Li, et al.
Publicado: (2013) -
Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer
por: Chen, Xuesong, et al.
Publicado: (2014) -
Increased Expression of Eps15 Homology Domain 1 is Associated with Poor Prognosis in Resected Small Cell Lung Cancer
por: Meng, Qingwei, et al.
Publicado: (2015) -
EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)